1Lok AS,McMahon BJ; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
2Farrell GC,George J,Pauline de la M.Hall and McCullough A J,eds.Fatty liver disease:NASH and related disorders.Oxford:Blackwell Publishing,2005,1-22.
3American Gastroenterological Association.American Gastroenterological Association Medical Position Statement:nonalcoholic fatty liver disease.Gastroenterology,2002,123:1702-1704.
8Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.
9Ataseven H,Yildrim MH,Yalniz M,et al.Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis.J Hepatol,2003,38(Suppl 2):A4177.
1Knuchel F. Double-blind study in patients with alcoholic fatty liver. The influence of "essential" phospholipids on enzyme behaviour and lipid composition of the serum. Med Welt, 1979, 30:411-416.
2Gonciarz Z, Besser P, Lelek E, et al. Randomized placebo-controlled double blind trial on "essential" phospholipids in the treatment of fatty liver associated with diabetes. Med Chir Digest, 1988, 17:61-65.
3Lieber CS, Weiss DG, Groszmann R, et al. Veterans affairs cooperative study polyenylphosphatidylcholine in alcoholic liver disease. Clin Exp Res,2003, 27: 1757-1764.
4Marlos Z, Pano S. Polyunsatturated phosphatidylcholine for acute alcoholic hepatitis: a double-blind randomized, placebo controlled trial. Eur J Gastroenterol Hepatol, 1990, 2: 351-355.
5Schuller P, Gonzalez F, Martins S, et al. Placebo-controlled study with polyunsaturated phosphatidylcholine in alcoholic steatosis of the liver. Med Welt, 1985, 36:517-52.
